Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 671

1.

Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.

Mulvahill JS, Nicol GE, Dixon D, Lenze EJ, Karp JF, Reynolds CF 3rd, Blumberger DM, Mulsant BH.

J Am Geriatr Soc. 2017 Dec;65(12):2651-2658. doi: 10.1111/jgs.15129.

PMID:
29235659
2.

Bone Turnover with Venlafaxine Treatment in Older Adults with Depression.

Rawson KS, Dixon D, Civitelli R, Peterson TR, Mulsant BH, Reynolds CF 3rd, Lenze EJ.

J Am Geriatr Soc. 2017 Sep;65(9):2057-2063. doi: 10.1111/jgs.14936. Epub 2017 May 26.

PMID:
28555718
3.

Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study.

Sonne C, Carlsson J, Bech P, Elklit A, Mortensen EL.

BMC Psychiatry. 2016 Nov 8;16(1):383.

4.

Venlafaxine and oxycodone have different effects on spinal and supraspinal activity in man: a somatosensory evoked potential study.

Lelic D, Valeriani M, Fischer IW, Dahan A, Drewes AM.

Br J Clin Pharmacol. 2017 Apr;83(4):764-776. doi: 10.1111/bcp.13177. Epub 2017 Jan 16.

PMID:
27808426
5.

Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.

Amsterdam JD, Lorenzo-Luaces L, DeRubeis RJ.

Bipolar Disord. 2016 Nov;18(7):563-570. doi: 10.1111/bdi.12442. Epub 2016 Nov 2.

6.

A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study.

Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, Young RC, Sampson S, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Rosenquist PB, Raza A, Kaliora S, Latoussakis V, Tobias KG, Briggs MC, Liebman LS, Geduldig ET, Teklehaimanot AA, Dooley M, Lisanby SH; CORE/PRIDE Work Group.

Am J Psychiatry. 2016 Nov 1;173(11):1110-1118. Epub 2016 Jul 15.

PMID:
27418381
7.

Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.

Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, Young RC, Sampson S, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Rosenquist PB, Raza A, Kaliora S, Latoussakis V, Tobias KG, Briggs MC, Liebman LS, Geduldig ET, Teklehaimanot AA, Lisanby SH; CORE/PRIDE Work Group.

Am J Psychiatry. 2016 Nov 1;173(11):1101-1109. Epub 2016 Jul 15.

PMID:
27418379
8.

Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

Richards C, McIntyre RS, Weisler R, Sambunaris A, Brawman-Mintzer O, Gao J, Geibel B, Dauphin M, Madhoo M.

J Affect Disord. 2016 Dec;206:151-160. doi: 10.1016/j.jad.2016.07.006. Epub 2016 Jul 5.

9.

Venlafaxine and oxycodone effects on human spinal and supraspinal pain processing: a randomized cross-over trial.

Lelic D, Fischer IW, Olesen AE, Mørch CD, Arguissain FG, Manresa JA, Dahan A, Drewes AM.

Eur J Neurosci. 2016 Dec;44(11):2966-2974. doi: 10.1111/ejn.13443. Epub 2016 Nov 25.

PMID:
27748551
10.

Impact of Prior Treatment on Remission of Late-Life Depression with Venlafaxine and Subsequent Aripiprazole or Placebo Augmentation.

Hsu JH, Mulsant BH, Lenze EJ, Karp JF, Lavretsky H, Roose SP, Reynolds CF 3rd, Blumberger DM.

Am J Geriatr Psychiatry. 2016 Oct;24(10):918-22. doi: 10.1016/j.jagp.2016.04.015. Epub 2016 May 6.

11.

Do Antidepressants Induce Psychosis in Children and Adolescents? A Naturalistic Study in Ambulatory Pediatric Population.

Mosheva M, Mekori E, Kantor S, Berg Y, Weizman A, Gothelf D.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):478-84. doi: 10.1089/cap.2015.0229. Epub 2016 May 11.

PMID:
27166781
12.

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.

Williams LM, Debattista C, Duchemin AM, Schatzberg AF, Nemeroff CB.

Transl Psychiatry. 2016 May 3;6:e799. doi: 10.1038/tp.2016.61.

13.

Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.

Grieve SM, Korgaonkar MS, Gordon E, Williams LM, Rush AJ.

J Clin Psychiatry. 2016 Apr;77(4):e436-43. doi: 10.4088/JCP.14m09577.

PMID:
27137427
14.

Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry.

Berm E, Kok R, Hak E, Wilffert B.

Pharmacopsychiatry. 2016 Sep;49(5):186-190. Epub 2016 Apr 21.

PMID:
27101231
15.

Acute Metabolic Changes Associated With Analgesic Drugs: An MR Spectroscopy Study.

Hansen TM, Olesen AE, Simonsen CW, Fischer IW, Lelic D, Drewes AM, Frøkjaer JB.

J Neuroimaging. 2016 Sep;26(5):545-51. doi: 10.1111/jon.12345. Epub 2016 Mar 30.

PMID:
27028269
16.

Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.

Shilyansky C, Williams LM, Gyurak A, Harris A, Usherwood T, Etkin A.

Lancet Psychiatry. 2016 May;3(5):425-35. doi: 10.1016/S2215-0366(16)00012-2. Epub 2016 Mar 16.

17.

[Comparative dynamics of EEG parameters in elderly depressive patients during monotherapy and combined therapy].

Iznak AF, Iznak EV, Kalyn YB, Safarova TP, Sheshenin VS, Gavrilova SI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(1):47-50. doi: 10.17116/jnevro20161161147-50. Russian.

PMID:
26977625
18.

Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.

Kaneriya SH, Robbins-Welty GA, Smagula SF, Karp JF, Butters MA, Lenze EJ, Mulsant BH, Blumberger D, Anderson SJ, Dew MA, Lotrich F, Aizenstein HJ, Diniz BS, Reynolds CF 3rd.

JAMA Psychiatry. 2016 Apr;73(4):329-36. doi: 10.1001/jamapsychiatry.2015.3447.

19.

Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.

Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, Kaiser AK, Kronfeld K, Schlicht KF, Tüscher O, Wagner S, Hiemke C, Lieb K.

Eur Neuropsychopharmacol. 2016 Apr;26(4):705-16. doi: 10.1016/j.euroneuro.2016.02.003. Epub 2016 Feb 9.

PMID:
26899588
20.

Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.

Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.

Br J Psychiatry. 2016 Apr;208(4):359-65. doi: 10.1192/bjp.bp.115.169375. Epub 2016 Feb 18.

Supplemental Content

Loading ...
Support Center